Becton Dickinson & Co. (BDX) has voluntarily recalled some 5.7 million products related to catheters and administering fluids intravenously, saying their use may cause serious injury or death.
The medical-technology company said it doesn't expect costs anticipated with the recall or the impact on its business to be "material."
Becton disclosed Monday that in October it recalled some lots of its Q-Syte Luer Access Devices. It added Monday that the recall has been expanded to NexivaT Closed IV Catheter systems, which include Q-Syte. Use of the products could cause an air embolism or leakage of blood or therapy that could result in serious injury or death, the company said. The company has notified customers worldwide via letter.
The Q-Syte needle-less connector is intended for use with infusion therapy products for the administration of fluids into the intravenous system. The Nexiva closed-catheter system includes two Q-Syte devices within its package that could be subject to the Q-Syte problem.
About 2.8 million Q-Syte devices and 2.9 million Nexiva units have been recalled. Affected products were distributed from November 2008 to November 2009. The company says the root cause has been corrected and preventive measures have been implemented.
Becton last month reported its fiscal first-quarter income rose 4% on higher-than-expected sales. Its shares were down 53 cents to $74.49 in recent trading.
No comments:
Post a Comment